Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 537,500.0 | $10.2M | 0.95% | NEW | — | $18.97 | -18.2% |
| 42 | PNTG | PENNANT GROUP INC | Healthcare | 357,346.0 | $10.1M | 0.94% | NEW | — | $28.15 | +25.5% |
| 43 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 605,000.0 | $9.8M | 0.92% | NEW | — | $16.24 | -20.2% |
| 44 | PEN | PENUMBRA INC | Healthcare | 31,500.0 | $9.8M | 0.92% | NEW | — | $310.91 | +5.0% |
| 45 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 144,500.0 | $9.6M | 0.90% | NEW | — | $66.39 | +10.2% |
| 46 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 374,450.0 | $9.4M | 0.88% | NEW | — | $25.12 | +63.3% |
| 47 | NTRA | NATERA INC | Healthcare | 40,500.0 | $9.3M | 0.87% | NEW | — | $229.09 | -16.0% |
| 48 | KURA | KURA ONCOLOGY IN | Healthcare | 872,000.0 | $9.1M | 0.85% | NEW | — | $10.39 | -11.5% |
| 49 | ACLX | ARCELLX INC | Healthcare | 133,500.0 | $8.7M | 0.81% | NEW | — | $65.20 | +76.5% |
| 50 | IDYA | IDEAYA Biosciences Inc | Healthcare | 250,000.0 | $8.6M | 0.81% | NEW | — | $34.57 | -18.1% |
| 51 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 106,255.0 | $8.4M | 0.78% | NEW | — | $78.99 | +20.9% |
| 52 | GH | GUARDANT HEALTH INC | Healthcare | 80,000.0 | $8.2M | 0.76% | NEW | — | $102.14 | -6.3% |
| 53 | RPRX | ROYALTY PHARMA PLC | Healthcare | 206,500.0 | $8.0M | 0.75% | NEW | — | $38.64 | +34.8% |
| 54 | BTSG | BRIGHTSPRING HEALTH SVCS INC | Healthcare | 198,000.0 | $7.4M | 0.69% | NEW | — | $37.45 | +51.5% |
| 55 | BRKR | BRUKER CORP | Healthcare | 147,315.0 | $6.9M | 0.65% | NEW | — | $47.11 | -9.6% |
| 56 | STOK | STOKE THERAPEUTICS INC | Healthcare | 216,000.0 | $6.9M | 0.64% | NEW | — | $31.74 | -8.5% |
| 57 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 81,600.0 | $6.2M | 0.58% | NEW | — | $76.49 | -13.7% |
| 58 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 139,000.0 | $6.2M | 0.58% | NEW | — | $44.82 | +19.8% |
| 59 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 1,238,625.0 | $6.2M | 0.58% | NEW | — | $4.99 | — |
| 60 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 25,000.0 | $6.2M | 0.58% | NEW | — | $246.54 | +18.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%